Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 13, 2018. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2018. Go to the latest filing (Q3 2026)

11.1B USDQ2 2018
Total value of stock positions
11.1B USD
Positions
31
Share of the ten largest
79.1%

The ten largest positions Q2 2018

  1. Twenty First Centy Fox Inc 17.6%▲ +48.2%
  2. Synchrony Financial 8.8%unchanged
  3. Cheniere Energy Inc 8.3%▼ −31.5%
  4. Viasat Inc 8.1%▲ +0.5%
  5. Qorvo Inc 7.9%unchanged
  6. Allergan PLC 7.4%▲ +4.2%
  7. Pioneer Nat Res Co 6.8%unchanged
  8. Twenty First Centy Fox Inc 6.0%▲ +19.0%
  9. Antero Res Corp 5.1%unchanged
  10. Colony Cap Inc New 2.8%new
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q2 2018

Positions Q2 2018 per 13F filing, 31 of 31
Symbol Weight Shares Reported value Change Held since
Viasat Inc 8.1% 13,732,068 902.5M USD +0.5% increased Q2 2013 or earlier 21 quarters
Novagold Res Inc 0.5% 13,467,145 59.9M USD unchanged Q2 2013 or earlier 21 quarters
Cheniere Energy Inc 8.3% 14,196,135 925.4M USD −31.5% reduced Q1 2014 18 quarters
Keryx Biopharmaceuticals Inc 0.9% 25,791,678 97.0M USD unchanged Q1 2014 18 quarters
Theravance Biopharma Inc 1.9% 9,309,168 211.1M USD unchanged Q2 2014 17 quarters
Antero Res Corp 5.1% 26,587,791 567.6M USD unchanged Q3 2014 16 quarters
Veritiv Corp 1.4% 3,824,385 152.4M USD unchanged Q3 2014 16 quarters
Atara Biotherapeutics Inc 2.1% 6,254,632 229.9M USD unchanged Q4 2014 15 quarters
Paratek Pharmaceuticals Inc 0.2% 2,394,498 24.4M USD unchanged Q4 2014 15 quarters
Twenty First Centy Fox Inc 17.6% 39,415,829 2.0B USD +48.2% increased Q3 2015 12 quarters
Twenty First Centy Fox Inc 6.0% 13,606,260 670.4M USD +19.0% increased Q3 2015 12 quarters
Allergan PLC 7.4% 4,950,000 825.3M USD +4.2% increased Q1 2016 10 quarters
SYF Synchrony Financial 8.8% 29,295,030 977.9M USD unchanged Q3 2016 8 quarters
Trilogy Metals Inc New 0.2% 13,050,758 23.2M USD +23.1% increased Q3 2016 8 quarters
CAH Cardinal Health 2.2% 5,100,000 249.0M USD unchanged Q4 2016 7 quarters
Gty Technology Holdings Inc 0.4% 4,400,000 45.9M USD unchanged Q4 2016 7 quarters
Saban Cap Acquisition Corp 0.2% 2,326,500 23.5M USD unchanged Q4 2016 7 quarters
Saban Cap Acquisition Corp < 0.1% 1,163,250 1.4M USD unchanged Q4 2016 7 quarters
Qorvo Inc 7.9% 11,000,000 881.9M USD unchanged Q1 2017 6 quarters
Pioneer Nat Res Co 6.8% 4,000,000 757.0M USD unchanged Q3 2017 4 quarters
MCK McKesson Corporation 2.0% 1,627,700 217.1M USD +0.7% increased Q3 2017 4 quarters
COR Cencora 1.4% 1,873,565 159.8M USD +42.2% increased Q3 2017 4 quarters
AMC AMC Entertainment 0.7% 5,000,000 79.5M USD unchanged Q3 2017 4 quarters
Sentinel Energy Svcs Inc 0.1% 1,600,000 16.1M USD unchanged Q4 2017 3 quarters
PCG PG&E Corporation 1.7% 4,500,000 191.5M USD +42.9% increased Q1 2018 2 quarters
Colony Cap Inc New 2.8% 49,687,370 310.0M USD new Q2 2018 1 quarter
T AT&T 2.7% 9,480,700 304.4M USD new Q2 2018 1 quarter
Tribune Media Co 1.0% 2,996,042 114.7M USD new Q2 2018 1 quarter
Sinclair Broadcast Group Inc 0.7% 2,571,302 82.7M USD new Q2 2018 1 quarter
Translate Bio Inc 0.2% 1,923,076 24.3M USD new Q2 2018 1 quarter
Shire PLC 0.2% 98,932 16.7M USD new Q2 2018 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 2 positions in convertible bonds and bonds worth 336.2M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Tesla Inc principal 250.0M USD 306.3M USD
  • Theravance Biopharma Inc principal 30.0M USD 30.0M USD

Breakdown by sector

  • Financials 8.8%
  • Health Care 5.6%
  • Communication Services 3.5%
  • Utilities 1.7%
  • not in our coverage 80.4%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close